A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS
一项针对肌萎缩侧索硬化症(ALS)患者的瑞德西姆替夫(Reldesemtiv)II期双盲随机剂量范围试验。
期刊:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
影响因子:2.8
doi:10.1080/21678421.2020.1822410
Shefner, Jeremy M; Andrews, Jinsy A; Genge, Angela; Jackson, Carlayne; Lechtzin, Noah; Miller, Timothy M; Cockroft, Bettina M; Meng, Lisa; Wei, Jenny; Wolff, Andrew A; Malik, Fady I; Bodkin, Cynthia; Brooks, Benjamin R; Caress, James; Dionne, Annie; Fee, Dominic; Goutman, Stephen A; Goyal, Namita A; Hardiman, Orla; Hayat, Ghazala; Heiman-Patterson, Terry; Heitzman, Daragh; Henderson, Robert D; Johnston, Wendy; Karam, Chafic; Kiernan, Matthew C; Kolb, Stephen J; Korngut, Lawrence; Ladha, Shafeeq; Matte, Genevieve; Mora, Jesus S; Needham, Merrilee; Oskarsson, Bjorn; Pattee, Gary L; Pioro, Erik P; Pulley, Michael; Quan, Dianna; Rezania, Kourosh; Schellenberg, Kerri L; Schultz, David; Shoesmith, Christen; Simmons, Zachary; Statland, Jeffrey; Sultan, Shumaila; Swenson, Andrea; Berg, Leonard H Van Den; Vu, Tuan; Vucic, Steve; Weiss, Michael; Whyte-Rayson, Ashley; Wymer, James; Zinman, Lorne; Rudnicki, Stacy A